Abstract
Within the mass spectrometric study of bisubstituted isoquinolines that possess great potential as prolylhydroxylase inhibitor drug candidates (e.g., FG-2216), unusually favored gas-phase formations of carboxylic acids after collisional activation were observed. The protonated molecule of [(1-chloro-4-hydroxy-isoquinoline-3-carbonyl)-amino]-acetic acid was dissociated, yielding the 1-chloro-4-hydroxy-isoquinoline-3-carboxylic acid methyleneamide cation. Subsequent dissociation caused the nominal elimination of 11 u that resulted from the loss of HCN and concomitant addition of oxygen to the product ion, which formed the protonated 1-chloro-4-hydroxy-isoquinoline-3-carboxylic acid. The preference of this structure under mass spectrometric conditions was substantiated by tandem mass spectrometry analyses using the corresponding methyl ester (1-chloro-4-hydroxy-isoquinoline-3-carboxylic acid methyl ester) that eliminated methylene (−14 u) upon collisional activation. Moreover, the major product ion of 1-chloro-4-hydroxy-isoquinoline-3-carboxylic acid, which resulted from the loss of water in MS3 experiments, restored the precursor ion structure by re-addition of H2O. Evidences for these phenomena were obtained by chemical synthesis of proposed gas-phase intermediates, H/D exchange experiments, high-resolution/high accuracy mass spectrometry at MSn level, and “ping-pong” analyses (MS7, in which the precursor ion was dissociated and the respective product ion isolated to regenerate the precursor ion for repeated dissociation. Based on these results, dissociation pathways for [(1-chloro-4-hydroxy-isoquinoline-3-carbonyl)-amino]-acetic acid were suggested that can be further utilized for the characterization of structurally related compounds or metabolic products in clinical, forensic, or doping control analysis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Pihlajaniemi, T.; Myllyla, R.; Kivirikko, K. I. Prolyl 4-Hydroxylase and Its Role in Collagen Synthesis. J. Hepatol. 1991, 13(Suppl 3), S2-S7.
Kivirikko, K. I.; Helaakoski, T.; Tasanen, K.; Vuori, K.; Myllyla, R.; Parkkonen, T.; Pihlajaniemi, T. Molecular Biology of Prolyl 4-Hydroxylase. Ann. N.Y. Acad. Sci. 1990, 580, 132–142.
Prockop, D. J.; Kivirikko, K. I. Collagens: Molecular Biology, Diseases, and Potentials for Therapy. Annu. Rev. Biochem. 1995, 64, 403–434.
Hirsilä, M.; Koivunen, P.; Günzler, V.; Kivirikko, K.; Myllyharju, J. Characterization of the Human Prolyl 4-Hydroxylases that Modify the Hypoxia-Inducible Factor. J. Biol. Chem. 2003, 278, 30772–30780.
Epstein, A. C.; Gleadle, J. M.; McNeill, L. A.; Hewitson, K. S.; O’Rourke, J.; Mole, D. R.; Mukherji, M.; Metzen, E.; Wilson, M. I.; Dhanda, A.; Tian, Y. M.; Masson, N.; Hamilton, D. L.; Jaakkola, P.; Barstead, R.; Hodgkin, J.; Maxwell, P. H.; Pugh, C. W.; Schofield, C. J.; Ratcliffe, P. J. C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl hydroxylation. Cell. 2001, 107, 43–54.
Bruick, R. K.; McKnight, S. L. A Conserved Family of Prolyl-4-Hydroxylases that Modify HIF. Science. 2001, 294, 1337–1340.
Jaakkola, P.; Mole, D. R.; Tian, Y. M.; Wilson, M. I.; Gielbert, J.; Gaskell, S. J.; Kriegsheim, A.; Hebestreit, H. F.; Mukherji, M.; Schofield, C. J.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J. Targeting of HIF-α to the von Hippel-Lindau ubiquitilation complex by O2-regulated prolyl hydroxylation. Science 2001, 292, 468–472.
Ivan, M.; Kondo, K.; Yang, H.; Kim, W.; Valiando, J.; Ohh, M.; Salic, A.; Asara, J. M.; Lane, W. S.; Kaelin, W. G., Jr. HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing. Science 2001, 292, 464–468.
Yu, F.; White, S. B.; Zhao, Q.; Lee, F. S. HIF-1α Binding to VHL is Regulated by Stimulus-Sensitive Proline Hydroxylation. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 9630–9635.
Safran, M.; Kaelin, W. G., Jr. HIF Hydroxylation and the Mammalian Oxygen-Sensing Pathway. J. Clin. Invest. 2003, 111, 779–783.
Metzen, E.; Ratcliffe, P. HIF Hydroxylation and Cellular Oxygen Sensing. Biol. Chem. 2004, 385, 223–230.
Bruick, R. Oxygen Sensing in the Hypoxic Response Pathway: Regulation of the Hypoxia-Inducible Transcription Factor. Genes Dev. 2003, 17, 2614–2623.
Warnecke, C.; Griethe, W.; Weidemann, A.; Jurgensen, J.; Willam, C.; Bachmann, S.; Ivashchenko, Y.; Wagner, I.; Frei, U.; Wiesener, M.; Eckardt, K. Activation of the Hypoxia-Inducible Factor Pathway and Stimulation of Angiogenesis by Application of Prolyl Hydroxylase Inhibitors. FASEB J. 2003, 17, 1186–1188.
Bruick, R. K.; McKnight, S. L. Building Better Vasculature. Genes Dev. 2001, 15, 2497–2502.
Jelkmann, W. Molecular Biology of Erythropoietin. Intern. Med. 2004, 43, 649–659.
Ratcliffe, P. From Erythropoietin to Oxygen: Hypoxia-Inducible Factor Hydroxylases and the Hypoxia Signal Pathway. Blood Purif. 2002, 20, 445–450.
del Peso, L.; Castellanos, M.; Temes, E.; Martin-Puig, S.; Cuevas, Y.; Olmos, G.; Landazuri, M. The von Hippel Lindau/Hypoxia-Inducible Factor (HIF) Pathway Regulates the Transcription of the HIF-Proline Hydroxylase Genes in Response to Low Oxygen. J. Biol. Chem. 2003, 278, 48690–48695.
Nietfeld, J.; de Jong, L.; Kemp, A. The Influence of 2-Oxoglutarate on the Activity of Prolyl 4-Hydroxylase. Biochim. Biophys. Acta. 1982, 704, 321–325.
Mole, D.; Schlemminger, I.; McNeill, L.; Hewitson, K.; Pugh, C.; Ratcliffe, P.; Schofield, C. 2-Oxoglutarate Analogue Inhibitors of HIF Prolyl Hydroxylase. Bioorg. Med. Chem. Lett. 2003, 13, 2677–2680.
Cunliffe, C.; Franklin, T. Inhibition of Prolyl 4-Hydroxylase by Hydroxyanthraquinones. Biochem. J. 1986, 239, 311–315.
Dowell, R.; Hadley, E. Novel Inhibitors of Prolyl 4-Hydroxylase. J. Med. Chem. 1992, 35, 800–804.
Wang, J.; Buss, J.; Chen, G.; Ponka, P.; Pantopoulos, K. The Prolyl 4-Hydroxylase Inhibitor Ethyl-3,4-Dihydroxybenzoate Generates Effective Iron Deficiency in Cultured Cells. FEBS Lett. 2002, 529, 309–312.
Warshakoon, N. C.; Wu, S.; Boyer, A.; Kawamoto, R.; Sheville, J.; Renock, S.; Xu, K.; Pokross, M.; Zhou, S.; Winter, C.; Walter, R.; Mekel, M.; Evdokimov, A. G. Structure-Based Design, Synthesis, and SAR Evaluation of a New Series of 8-Hydroxyquinolines as HIF-1α Prolyl Hydroxylase Inhibitors. Bioorg. Med. Chem. Lett. 2006, 16, 5517–5522.
Warshakoon, N. C.; Wu, S.; Boyer, A.; Kawamoto, R.; Renock, S.; Xu, K.; Pokross, M.; Evdokimov, A. G.; Zhou, S.; Winter, C.; Walter, R.; Mekel, M. Design and Synthesis of a Series of Novel Pyrazolopyridines as HIF-1α Prolyl Hydroxylase Inhibitors. Bioorg. Med. Chem. Lett. 2006, 16, 5687–5690.
Tucker, H.; Thomas, D. Novel Inhibitors of Prolyl 4-Hydroxylase: 2. 5-Amide Substituted pyridine-2-carboxylic acids. J. Med. Chem. 1992, 35, 804–807.
Hales, N.; Beattie, J. Novel Inhibitors of Prolyl 4-Hydroxylase: 5. The Intriguing Structure-Activity Relationships Seen with 2,2′-Bipyridine and Its 5,5′-Dicarboxylic Acid Derivatives. J. Med. Chem. 1993, 36, 3853–3858.
Cunliffe, C.; Franklin, T.; Hales, N.; Hill, G. Novel Inhibitors of Prolyl 4-Hydroxylase: 3. Inhibition by the Substrate Analogue N-Oxaloglycine and Its Derivatives. J. Med. Chem. 1992, 35, 2652–2658.
Baader, E.; Tschank, G.; Baringhaus, K.; Burghard, H.; Gunzler, V. Inhibition of Prolyl 4-Hydroxylase by Oxalyl Amino Acid Derivatives in Vitro, in Isolated Microsomes and in Embryonic Chicken Tissues. Biochem. J. 1994, 300, 525–530.
Fibrogen Inc. Development Pipeline. 2007, http://www.fibrogen.com/pipeline/chart/anemia.html#mid (accessed 09-20-2007).
Wang, Q.; Gou, G.; Guenzler, V.; Neff, T.; Klaus, S.; Turtle, E.; Molineaux, C.; Yeowell, D.; Lin, A. Stimulation of Erythropoiesis and Treatment of Anemia in Rodents by Oral Administration of FG-2216, a Novel HIF-Prolyl Hydroxylase Inhibitor. J. Am. Soc. Nephrol. 2004, 15, 773A.
Hsieh, M. M.; Linde, N. S.; Wynter, A.; Metzger, M.; Wong, C.; Langsetmo, I.; Lin, A.; Smith, R.; Rodgers, G. P.; Donahue, R. E.; Klaus, S. J.; Tisdale, J. F. HIF Prolyl Hydroxylase Inhibition Results in Endogenous Erythropoietin Induction, Erythrocytosis, and Modest Fetal Hemoglobin Expression in Rhesus Macaques. Blood. 2007, 110, 2140–2147.
Suzuki, M.; Nunami, K.; Matsumoto, K.; Yoneda, N.; Miyoshi, M. A Facile Synthesis of 1-Oxo-1,2-Dihydroxyisoquinoline-3-Carboxylate and 2-Pyridone-6-Carboxylate Derivatives. Synthesis. 1978, 461–462.
Fibrogen. EP 1 538 160 A1, European Patent Office: 2005.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published online November 9, 2007
Rights and permissions
About this article
Cite this article
Thevis, M., Kohler, M., Schlörer, N. et al. Gas phase reaction of substituted isoquinolines to carboxylic acids in ion trap and triple quadrupole mass spectrometers after electrospray ionization and collision-induced dissociation. J. Am. Soc. Spectrom. 19, 151–158 (2008). https://doi.org/10.1016/j.jasms.2007.11.003
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jasms.2007.11.003